Select Medical Holdings Corporation (NYSE:SEM - Get Free Report) has been given an average rating of "Moderate Buy" by the five research firms that are currently covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 1 year target price among brokerages that have issued a report on the stock in the last year is $26.00.
A number of equities research analysts have commented on the stock. Mizuho assumed coverage on shares of Select Medical in a report on Wednesday, April 16th. They issued an "outperform" rating and a $25.00 price target for the company. Royal Bank Of Canada cut their price objective on shares of Select Medical from $23.00 to $19.00 and set an "outperform" rating on the stock in a research report on Wednesday, May 7th.
View Our Latest Report on SEM
Insider Activity at Select Medical
In related news, Director Parvinderjit S. Khanuja bought 21,000 shares of the business's stock in a transaction that occurred on Monday, May 5th. The shares were bought at an average price of $15.02 per share, with a total value of $315,420.00. Following the completion of the transaction, the director directly owned 65,089 shares in the company, valued at approximately $977,636.78. This represents a 47.63% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO David S. Chernow sold 225,000 shares of the stock in a transaction on Monday, April 28th. The shares were sold at an average price of $18.00, for a total value of $4,050,000.00. Following the completion of the sale, the chief executive officer directly owned 714,516 shares of the company's stock, valued at $12,861,288. The trade was a 23.95% decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 11.60% of the company's stock.
Institutional Investors Weigh In On Select Medical
Institutional investors have recently added to or reduced their stakes in the company. LPL Financial LLC grew its stake in Select Medical by 2.0% in the 4th quarter. LPL Financial LLC now owns 31,441 shares of the health services provider's stock valued at $593,000 after buying an additional 619 shares in the last quarter. Vista Finance LLC lifted its position in shares of Select Medical by 7.0% during the first quarter. Vista Finance LLC now owns 10,969 shares of the health services provider's stock worth $183,000 after acquiring an additional 716 shares in the last quarter. Net Worth Advisory Group grew its position in shares of Select Medical by 6.4% in the first quarter. Net Worth Advisory Group now owns 14,045 shares of the health services provider's stock valued at $235,000 after purchasing an additional 846 shares in the last quarter. Bank of Montreal Can grew its position in shares of Select Medical by 4.5% in the fourth quarter. Bank of Montreal Can now owns 20,030 shares of the health services provider's stock valued at $378,000 after purchasing an additional 867 shares in the last quarter. Finally, Sterling Capital Management LLC lifted its holdings in Select Medical by 9.5% during the 4th quarter. Sterling Capital Management LLC now owns 11,304 shares of the health services provider's stock worth $213,000 after purchasing an additional 978 shares in the last quarter. 89.48% of the stock is owned by institutional investors.
Select Medical Trading Up 1.0%
Shares of NYSE:SEM traded up $0.15 during midday trading on Monday, reaching $15.28. The company's stock had a trading volume of 378,267 shares, compared to its average volume of 978,335. Select Medical has a fifty-two week low of $14.03 and a fifty-two week high of $40.98. The company has a debt-to-equity ratio of 0.87, a quick ratio of 1.16 and a current ratio of 1.16. The firm has a 50 day moving average price of $15.35 and a two-hundred day moving average price of $17.13. The firm has a market capitalization of $1.96 billion, a price-to-earnings ratio of 11.40, a PEG ratio of 0.81 and a beta of 1.32.
Select Medical (NYSE:SEM - Get Free Report) last issued its quarterly earnings results on Thursday, May 1st. The health services provider reported $0.44 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.45 by ($0.01). The business had revenue of $1.35 billion during the quarter, compared to analyst estimates of $1.40 billion. Select Medical had a net margin of 2.81% and a return on equity of 11.04%. Select Medical's quarterly revenue was down 24.4% compared to the same quarter last year. During the same period last year, the firm posted $0.75 earnings per share. As a group, analysts forecast that Select Medical will post 1.17 earnings per share for the current year.
Select Medical Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Thursday, May 29th. Shareholders of record on Thursday, May 15th were paid a dividend of $0.0625 per share. The ex-dividend date of this dividend was Thursday, May 15th. This represents a $0.25 dividend on an annualized basis and a yield of 1.64%. Select Medical's dividend payout ratio (DPR) is currently 18.66%.
Select Medical announced that its Board of Directors has approved a share repurchase program on Thursday, May 1st that authorizes the company to buyback $1.00 billion in shares. This buyback authorization authorizes the health services provider to purchase up to 42.6% of its shares through open market purchases. Shares buyback programs are often a sign that the company's board believes its stock is undervalued.
Select Medical Company Profile
(
Get Free ReportSelect Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.
Featured Articles

Before you consider Select Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Select Medical wasn't on the list.
While Select Medical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.